Lewis Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,131
Closed -$151K 136
2024
Q4
$151K Sell
10,131
-1,005
-9% -$16.4K 0.12% 128
2024
Q3
$213K Buy
+11,136
New +$231K 0.16% 124
2024
Q1
Sell
-10,600
Closed -$153K 122
2023
Q4
$153K Buy
+10,600
New +$144K 0.14% 106

Other funds holding OGN

Lewis Asset Management's OGN Position: Q1 2025 in Review

Lewis Asset Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 10,131 shares — an estimated $151K sold.

Lewis Asset Management first reported a position in OGN in Q4 2023 and held it in 3 quarters. The position peaked at $213K in Q3 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Lewis Asset Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Lewis Asset Management sold 10,131 Organon & Co shares in Q1 2025, an estimated $151K.
  • Lewis Asset Management first reported a position in Organon & Co in Q4 2023 and held it in 3 quarters.
  • Lewis Asset Management's Organon & Co position peaked at $213K in Q3 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Lewis Asset Management's 13F filing for Q1 2025, filed 5 May 2025.